Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Pasireotide Treatment for Neuroendocrine Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02779257
Recruitment Status : Withdrawn (Subject passed away prior to enrollment)
First Posted : May 20, 2016
Last Update Posted : November 7, 2019
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Kashif Munir, University of Maryland, College Park

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : June 2016
Actual Study Completion Date : June 2016